Search research articles
Contact Us
Filters
Showing results (51-60 of 177) with videos related to
Page
of 18
Sort By:
Digestive Diseases and Sciences
|
August 22, 2019
Access to Comprehensive Services for Advanced Liver Disease in the Veterans Health Administration
S Hunter Dunn, Shari S Rogal, Marissa M Maier, et al.
Open Forum Infectious Diseases
|
May 19, 2025
Hepatitis C Testing in the US Veterans Health Administration: Uptake of United States Preventive Services Taskforce Universal Hepatitis C Screening Guidance
Cara D Varley, Lauren A Beste, Elliott Lowy, et al.
Hepatology (Baltimore, Md.)
|
March 5, 2011
Occult and previous hepatitis B virus infection are not associated with hepatocellular carcinoma in United States patients with chronic hepatitis C
Anna S Lok, James E Everhart, Adrian M Di Bisceglie, et al.
European Journal of Gastroenterology & Hepatology
|
September 17, 2008
Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease
Kengathevy Morgan, Adhemar Uyuni, Ganesh Nandgiri, et al.
Hepatology (Baltimore, Md.)
|
October 18, 2024
Resmetirom therapy for metabolic dysfunction-associated steatotic liver disease: October 2024 updates to AASLD Practice Guidance
Vincent L Chen, Timothy R Morgan, Yaron Rotman, et al.
Federal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS
|
February 16, 2019
Achieving Excellence in Hepatitis B Virus Care for Veterans in the Veterans Health Administration
Maggie Chartier, Marissa M Maier, Timothy R Morgan, et al.
Hepatology (Baltimore, Md.)
|
February 12, 2025
Erratum: Resmetirom therapy for metabolic dysfunction-associated steatotic liver disease: October 2024 updates to AASLD Practice Guidance
Vincent L Chen, Timothy R Morgan, Yaron Rotman, et al.
Clinical Liver Disease
|
July 7, 2022
Improving quality of hepatitis B care in the Veteran's Health Administration
Karine Rozenberg-Ben-Dror, Marissa M Maier, Lauren Beste, et al.
Hepatology (Baltimore, Md.)
|
February 14, 2025
Reply: AASLD Resmetirom Guidance
Vincent L Chen, Timothy R Morgan, Yaron Rotman, et al.
Alcoholism, Clinical and Experimental Research
|
March 11, 2020
Differential Activation of Unconventional T Cells, Including iNKT Cells, in Alcohol-Related Liver Disease
Idania Marrero, Igor Maricic, Timothy R Morgan, et al.
Page
of 18
Search research articles
Search
Showing results (51-60 of 177) with videos related to
Sort By:
Page
of 18
Digestive Diseases and Sciences
|
August 22, 2019
Access to Comprehensive Services for Advanced Liver Disease in the Veterans Health Administration
S Hunter Dunn, Shari S Rogal, Marissa M Maier, et al.
Open Forum Infectious Diseases
|
May 19, 2025
Hepatitis C Testing in the US Veterans Health Administration: Uptake of United States Preventive Services Taskforce Universal Hepatitis C Screening Guidance
Cara D Varley, Lauren A Beste, Elliott Lowy, et al.
Hepatology (Baltimore, Md.)
|
March 5, 2011
Occult and previous hepatitis B virus infection are not associated with hepatocellular carcinoma in United States patients with chronic hepatitis C
Anna S Lok, James E Everhart, Adrian M Di Bisceglie, et al.
European Journal of Gastroenterology & Hepatology
|
September 17, 2008
Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease
Kengathevy Morgan, Adhemar Uyuni, Ganesh Nandgiri, et al.
Hepatology (Baltimore, Md.)
|
October 18, 2024
Resmetirom therapy for metabolic dysfunction-associated steatotic liver disease: October 2024 updates to AASLD Practice Guidance
Vincent L Chen, Timothy R Morgan, Yaron Rotman, et al.
Federal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS
|
February 16, 2019
Achieving Excellence in Hepatitis B Virus Care for Veterans in the Veterans Health Administration
Maggie Chartier, Marissa M Maier, Timothy R Morgan, et al.
Hepatology (Baltimore, Md.)
|
February 12, 2025
Erratum: Resmetirom therapy for metabolic dysfunction-associated steatotic liver disease: October 2024 updates to AASLD Practice Guidance
Vincent L Chen, Timothy R Morgan, Yaron Rotman, et al.
Clinical Liver Disease
|
July 7, 2022
Improving quality of hepatitis B care in the Veteran's Health Administration
Karine Rozenberg-Ben-Dror, Marissa M Maier, Lauren Beste, et al.
Hepatology (Baltimore, Md.)
|
February 14, 2025
Reply: AASLD Resmetirom Guidance
Vincent L Chen, Timothy R Morgan, Yaron Rotman, et al.
Alcoholism, Clinical and Experimental Research
|
March 11, 2020
Differential Activation of Unconventional T Cells, Including iNKT Cells, in Alcohol-Related Liver Disease
Idania Marrero, Igor Maricic, Timothy R Morgan, et al.
Page
of 18